- Source type
- Government
- Access type
- Official
- Publisher
- U.S. Food and Drug Administration
- Date
- 2023-10-10
- Added
- 2026-07-04
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
94
U.S. health regulator
- Publisher type
- Regulator
- Bias profile
- Low
This source is strongest for regulatory status and safety and weaker for consumer context and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 98/100
- Primary Anchor
- Clinical outcomes
- 84/100
- Strong Support
- Mechanism
- 68/100
- Context Source
- Safety
- 95/100
- Primary Anchor
- Consumer context
- 68/100
- Context Source
- Trial discovery
- 68/100
- Context Source
Best used for
- Approvals
- Labels
- Safety communications
Weak for
- Comparative effectiveness
- Consumer experience
Used in Viral Vitalism
Does Cannabis Shrink Your Brain?
Roles: Regulatory status
Show section-level references
FDA warns patients and health care providers about potential risks associated with compounded ketamine products
Roles: Regulatory status
Show section-level references
Claim ledger
Claims supported
Reviewed claim cards that cite this source in the evidence graph.
ketamine: Ketamine should not be framed as a casual relaxation
Ketamine should not be framed as a casual relaxation substitute for cannabis; FDA warns about meaningful safety and monitoring concerns for compounded ketamine products.
cannabis: The broad claim that cannabis shrinks your brain overstates
The broad claim that cannabis shrinks your brain overstates a mixed evidence base and swaps endpoints such as perfusion, activation, volume, and cognition.
Related studies
Related sources
FDA: Tainted Products Marketed as Dietary Supplements
Regulatory safety source for supplement adulteration and tainted-product risk, used to ground the consumer-safety layer around cleanse stacks, detox products, and unverified supplement protocols.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
AABB: FDA warns against use of unapproved HCT/Ps
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- AABB
- Access
- Publisher
- Usage
- 1 connection
CDC: Parasites Diagnosis
Government diagnostic-context source used to keep parasite concern tied to exposure history, organism-specific evaluation, clinical symptoms, and appropriate testing rather than vague wellness symptoms.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 13 connections
EPA: A Brief Guide to Mold, Moisture and Your Home
Government environmental-health source for the core remediation rule: fix moisture, clean mold, dry water damage quickly, and do not treat testing as the primary intervention.
- Trust score
- 91
- Publisher
- U.S. Environmental Protection Agency
- Access
- Official
- Usage
- 12 connections
FDA clarifies policies for compounders as GLP-1 supply stabilizes
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 3 connections
FDA Q&A: Proposed order for over-the-counter sunscreen
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 9 connections